Literature DB >> 18313941

Zernike phase contrast electron microscopy of ice-embedded influenza A virus.

Masashi Yamaguchi1, Radostin Danev, Kiyoto Nishiyama, Keishin Sugawara, Kuniaki Nagayama.   

Abstract

The ultrastructure of the frozen-hydrated influenza A virus was examined by Zernike phase contrast electron microscopy. Using this new microscopy, not only lipid bilayers but also individual glycoprotein spikes on viral envelopes were clearly resolved with high contrast in micrographs taken in focus. In addition to spherical and elongated virions, three other classes of virions were distinguished on the basis of the features of their viral envelope: virions with a complete matrix layer, which were the most predominant, virions with a partial matrix layer, and virions with no matrix layer under the lipid bilayer. About 450 glycoprotein spikes were present in an average-sized spherical virion. Eight ribonucleoprotein complexes, that is, a central one surrounded by seven others, were distinguished in one viral particle. Thus, Zernike phase contrast electron microscopy is a powerful tool for resolving the ultrastructure of viruses, because it enables high-contrast images of ice-embedded particles free of contrast transfer function artifacts that can be a problem in conventional cryo-electron microscopy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313941     DOI: 10.1016/j.jsb.2008.01.009

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  47 in total

1.  Retrofit implementation of Zernike phase plate imaging for cryo-TEM.

Authors:  Michael Marko; Ardean Leith; Chyongere Hsieh; Radostin Danev
Journal:  J Struct Biol       Date:  2011-01-25       Impact factor: 2.867

2.  Structural changes in Influenza virus at low pH characterized by cryo-electron tomography.

Authors:  Juan Fontana; Giovanni Cardone; J Bernard Heymann; Dennis C Winkler; Alasdair C Steven
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

3.  Methods for testing Zernike phase plates and a report on silicon-based phase plates with reduced charging and improved ageing characteristics.

Authors:  Michael Marko; Xing Meng; Chyongere Hsieh; James Roussie; Christopher Striemer
Journal:  J Struct Biol       Date:  2013-08-28       Impact factor: 2.867

4.  Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.

Authors:  Joshua S Klein; Priyanthi N P Gnanapragasam; Rachel P Galimidi; Christopher P Foglesong; Anthony P West; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

Review 5.  Invited review article: Methods for imaging weak-phase objects in electron microscopy.

Authors:  Robert M Glaeser
Journal:  Rev Sci Instrum       Date:  2013-11       Impact factor: 1.523

6.  Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus.

Authors:  Edward C Hutchinson; Martin D Curran; Eliot K Read; Julia R Gog; Paul Digard
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

7.  The Stabilities of the Soluble Ectodomain and Fusion Peptide Hairpins of the Influenza Virus Hemagglutinin Subunit II Protein Are Positively Correlated with Membrane Fusion.

Authors:  Ahinsa Ranaweera; Punsisi U Ratnayake; David P Weliky
Journal:  Biochemistry       Date:  2018-09-05       Impact factor: 3.162

Review 8.  HIV-1 and influenza antibodies: seeing antigens in new ways.

Authors:  Peter D Kwong; Ian A Wilson
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

9.  Few and far between: how HIV may be evading antibody avidity.

Authors:  Joshua S Klein; Pamela J Bjorkman
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

10.  Characterisation of influenza A viruses with mutations in segment 5 packaging signals.

Authors:  Edward C Hutchinson; Helen M Wise; Katerine Kudryavtseva; Martin D Curran; Paul Digard
Journal:  Vaccine       Date:  2009-10-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.